JULIAN ADAMS

CIK 1230486 · Chief Executive Officer · last filed 2025-05-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

24

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ELTX Director $14.85 $0 3 2025-05-20
Gamida Cell Ltd. (GMDA) Delisted Chief Executive Officer 423,750 $0.03 $13.9K $0 5 2024-02-02
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Director $13.60 $0 3 2018-01-29
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted President of R&D 322,095 $0.04 $14.4K $0 13 2016-11-02

Recent Filings · Page 3 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-12-08 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2008-10-30 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Exer (M) +137,413 $320.6K EDGAR
2007-12-14 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
2007-01-29 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) $0 EDGAR
Showing 2124 of 24
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.